首页 > 最新文献

Journal of gynecology obstetrics and human reproduction最新文献

英文 中文
Experience in medical treatment of ectopic pregnancy, cesarean scar with three comparative methods: Methotrexate intra-gestational-sac injection, ultrasound-guided KCL injection, and hysteroscopy-assisted resection 甲氨蝶呤卵囊内注射、超声引导下KCL注射、宫腔镜辅助切除三种比较方法治疗异位妊娠、剖宫产瘢痕的体会。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-10-17 DOI: 10.1016/j.jogoh.2025.103056
Nazli Navali , Saeedeh Mardi , Solmaz Fallahi

Introduction

Cesarean scar pregnancy (CSP) presents significant risks to the mother, and there is no consensus on the optimal treatment for this condition. This study was conducted to compare the effectiveness of three interventions: methotrexate (MTX) intra-gestational sac injection, potassium chloride (KCL) intra-gestational sac injection under ultrasound guidance, and hysteroscopic resection.

Methods

Women with CSP were enrolled and randomly assigned to three groups: (1) MTX injection with curettage, (2) KCl injection with curettage, and (3) hysteroscopic resection performed one day after intramuscular MTX administration. Discharge was scheduled for the following day, provided there were no complications. Weekly follow-up assessments included measuring serum β-human chorionic gonadotropin (β-hCG) levels.

Results

No statistically significant differences were observed in serum β-hCG levels among the groups before treatment or after intervention (p-value=0.396 and p-value=0.095, respectively). The length of hospitalization did not differ significantly between the groups (p = 0.903). Similarly, the time to β-hCG normalization showed no significant variation (p = 0.426). All three treatment strategies effectively achieved complete resolution, with a marked decline in serum β-hCG levels across all participants.

Conclusion

The comparative analysis indicates equivalent efficacy among the three interventions in terms of gestational sac resolution and β-hCG clearance time. No cases of uterine perforation, hemorrhage, hysterectomy, or extended hospitalization were reported following any of the treatments.
剖宫产疤痕妊娠(CSP)对母亲有显著的风险,对于这种情况的最佳治疗尚无共识。本研究比较甲氨蝶呤(MTX)妊娠囊内注射、超声引导下氯化钾(KCL)妊娠囊内注射和宫腔镜切除三种干预措施的有效性。方法:将患有CSP的女性随机分为三组:(1)注射甲氨蝶呤并刮宫,(2)注射氯化钾并刮宫,(3)肌注甲氨蝶呤1天后行宫腔镜切除。如果没有并发症,预定第二天出院。每周随访评估包括测定血清β-人绒毛膜促性腺激素(β-hCG)水平。结果:治疗前、干预后各组血清β-hCG水平差异无统计学意义(p值分别为0.396、0.095)。两组住院时间差异无统计学意义(p = 0.903)。同样,到β-hCG正常化的时间也没有显著变化(p = 0.426)。所有三种治疗策略都有效地实现了完全的解决,所有参与者的血清β-hCG水平显著下降。结论:对比分析表明,三种干预措施在妊娠囊溶解和β-hCG清除时间方面效果相当。没有病例报告子宫穿孔,出血,子宫切除术,或延长住院治疗后的任何治疗。
{"title":"Experience in medical treatment of ectopic pregnancy, cesarean scar with three comparative methods: Methotrexate intra-gestational-sac injection, ultrasound-guided KCL injection, and hysteroscopy-assisted resection","authors":"Nazli Navali ,&nbsp;Saeedeh Mardi ,&nbsp;Solmaz Fallahi","doi":"10.1016/j.jogoh.2025.103056","DOIUrl":"10.1016/j.jogoh.2025.103056","url":null,"abstract":"<div><h3>Introduction</h3><div>Cesarean scar pregnancy (CSP) presents significant risks to the mother, and there is no consensus on the optimal treatment for this condition. This study was conducted to compare the effectiveness of three interventions: methotrexate (MTX) intra-gestational sac injection, potassium chloride (KCL) intra-gestational sac injection under ultrasound guidance, and hysteroscopic resection.</div></div><div><h3>Methods</h3><div>Women with CSP were enrolled and randomly assigned to three groups: (1) MTX injection with curettage, (2) KCl injection with curettage, and (3) hysteroscopic resection performed one day after intramuscular MTX administration. Discharge was scheduled for the following day, provided there were no complications. Weekly follow-up assessments included measuring serum β-human chorionic gonadotropin (β-hCG) levels.</div></div><div><h3>Results</h3><div>No statistically significant differences were observed in serum β-hCG levels among the groups before treatment or after intervention (p-value=0.396 and p-value=0.095, respectively). The length of hospitalization did not differ significantly between the groups (<em>p</em> = 0.903). Similarly, the time to β-hCG normalization showed no significant variation (p = 0.426). All three treatment strategies effectively achieved complete resolution, with a marked decline in serum β-hCG levels across all participants.</div></div><div><h3>Conclusion</h3><div>The comparative analysis indicates equivalent efficacy among the three interventions in terms of gestational sac resolution and β-hCG clearance time. No cases of uterine perforation, hemorrhage, hysterectomy, or extended hospitalization were reported following any of the treatments.</div></div>","PeriodicalId":15871,"journal":{"name":"Journal of gynecology obstetrics and human reproduction","volume":"55 1","pages":"Article 103056"},"PeriodicalIF":1.6,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145312959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Morbidity of surgical induced abortion between 14 and 16 weeks of gestation 妊娠14 ~ 16周手术流产的发病率。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-10-17 DOI: 10.1016/j.jogoh.2025.103055
Aurélie Jugnet , Lise Amart , Hamza Benjelloun , Mathilde Gibier , Claire Burnet , Héléne Piclet , Aubert Agostini

Objective

To assess the morbidity associated with surgical induced abortion (SIA) using the dilation and evacuation (D&E) technique between 14 and 16 weeks of gestation (WG).

Material and Methods

A retrospective single-center cohort study was conducted at Hôpital de la Conception, Marseille, including patients who underwent SIA between 14 and 16 WG from April 4, 2022, to February 8, 2024.

Results

Among the 127 patients included, 17 cases (13.39%) of haemorrhage (blood loss > 500 mL) were reported, 1 case (0.79%) required a hemostatic hysterectomy and a blood transfusion due to placenta accreta, 2 cases (1.57%) involved cervical lacerations, and 2 cases (1.57%) postoperative infections. No uterine perforations or secondary surgeries for retained products were reported. Blood loss volume decreased over the course of the study (beta -0.55; 95% CI -0.79, -0.30; p < 0.001).

Conclusion

SIA using the D&E method between 14 and 16 WG is a procedure with a low risk of major complications. As with any surgical procedure, this technique requires a learning curve.
目的:探讨妊娠14 ~ 16周采用扩排术(D&E)手术人工流产(SIA)的相关发病率。材料和方法:在Hôpital de la Conception, Marseille进行了一项回顾性单中心队列研究,纳入了2022年4月4日至2024年2月8日期间14至16 WG期间接受SIA的患者。结果:本组127例患者中,出血17例(占13.39%)(出血量500ml),因胎盘增生需止血子宫切除输血1例(占0.79%),宫颈裂伤2例(占1.57%),术后感染2例(占1.57%)。没有子宫穿孔或二次手术保留产品的报道。在整个研究过程中,失血量减少(β -0.55; 95% CI -0.79, -0.30; p < 0.001)。结论:采用D&E方法在14 ~ 16 WG间行SIA手术,主要并发症风险低。与任何外科手术一样,这项技术需要一个学习曲线。
{"title":"Morbidity of surgical induced abortion between 14 and 16 weeks of gestation","authors":"Aurélie Jugnet ,&nbsp;Lise Amart ,&nbsp;Hamza Benjelloun ,&nbsp;Mathilde Gibier ,&nbsp;Claire Burnet ,&nbsp;Héléne Piclet ,&nbsp;Aubert Agostini","doi":"10.1016/j.jogoh.2025.103055","DOIUrl":"10.1016/j.jogoh.2025.103055","url":null,"abstract":"<div><h3>Objective</h3><div>To assess the morbidity associated with surgical induced abortion (SIA) using the dilation and evacuation (D&amp;E) technique between 14 and 16 weeks of gestation (WG).</div></div><div><h3>Material and Methods</h3><div>A retrospective single-center cohort study was conducted at Hôpital de la Conception, Marseille, including patients who underwent SIA between 14 and 16 WG from April 4, 2022, to February 8, 2024.</div></div><div><h3>Results</h3><div>Among the 127 patients included, 17 cases (13.39%) of haemorrhage (blood loss &gt; 500 mL) were reported, 1 case (0.79%) required a hemostatic hysterectomy and a blood transfusion due to placenta accreta, 2 cases (1.57%) involved cervical lacerations, and 2 cases (1.57%) postoperative infections. No uterine perforations or secondary surgeries for retained products were reported. Blood loss volume decreased over the course of the study (beta -0.55; 95% CI -0.79, -0.30; <em>p</em> &lt; 0.001).</div></div><div><h3>Conclusion</h3><div>SIA using the D&amp;E method between 14 and 16 WG is a procedure with a low risk of major complications. As with any surgical procedure, this technique requires a learning curve.</div></div>","PeriodicalId":15871,"journal":{"name":"Journal of gynecology obstetrics and human reproduction","volume":"54 10","pages":"Article 103055"},"PeriodicalIF":1.6,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145318399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fetal monitoring in pregnancies at and beyond 41 completed weeks: Prospective blind observational study of the use of umbilical and middle cerebral artery Doppler 41周及以上妊娠期胎儿监测:脐带和大脑中动脉多普勒应用的前瞻性盲观察研究
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-10-15 DOI: 10.1016/j.jogoh.2025.103054
Jeremy Boujenah, Bernard Benoit, Reda Djafer, Jacques Raiga, Guillaume Benoist, Bruno Carbonne

Objectives

To assess the association of umbilical and middle cerebral artery Doppler, with the need for medical intervention during labor and the occurrence of adverse neonatal outcome in pregnancies at/or beyond 41 weeks.

Methods

Prospective, observational study of all pregnant women at 41 weeks and beyond during one year in a single Maternity Unit. Doppler measurements of umbilical artery and middle cerebral artery resistance indices (UA-RI and MCA-RI) and cerebro placental ratio (CPR) were performed at 41 weeks, blinded to the clinical staff. Clinical management of prolonged pregnancy was based on routine antepartum fetal heart rate (FHR) monitoring and ultrasound assessment of oligohydramnios. The main outcome measures were 2 composite criteria: 1) “medical intervention during labor” including any of cesarean delivery for FHR abnormalities and/or need for fetal scalp blood sampling for lactate measurement; and 2) “suboptimal neonatal outcome” including any of 5-min Apgar score < 7, umbilical cord artery pH < 7.15, transfer to neonatal unit or perinatal death. The association between abnormal fetal Doppler and the outcome criteria was assessed.

Results

Out of 116 women recruited (12.3 % of all deliveries), 30 (25.9 %) had a medical intervention during labor and 16 (13.8 %) had a suboptimal neonatal outcome. None of antepartum FHR or oligohydramnios were associated with any of the primary outcomes. UA-RI and cerebro-placental ratio were strongly associated with the need for a medical intervention during labor (OR [95 % CI] 13.1 [1.4 – 122.2] and 5.1 [1.3 19.7], respectively) but not with the occurrence or a suboptimal neonatal outcome. If made available to the clinical staff, abnormal fetal Dopplers could have led to 12 additional inductions of labor and to the adequate identification of 13 interventions during labor including 6 cesareans for abnormal FHR.

Conclusion

Abnormal fetal Doppler beyond 41 weeks may help to better identify situations at risk for medical intervention for fetal concern during labor. Further studies are necessary to assess its prospective use for the management of prolonged pregnancies
目的:评估妊娠41周及以上产妇产程中脐带和大脑中动脉多普勒与医疗干预的需要和新生儿不良结局的发生的关系。方法:前瞻性,观察性研究所有41周及以上的孕妇在一个单一的产科病房一年。41周时,在临床工作人员不知情的情况下,进行脐动脉和大脑中动脉阻力指数(UA-RI和MCA-RI)和脑胎盘比(CPR)的多普勒测量。延长妊娠的临床处理以产前常规胎心率监测和羊水过少超声评估为基础。主要结局指标为2个综合标准:1)“分娩过程中的医疗干预”,包括因FHR异常和/或需要进行胎儿头皮血液采样以测量乳酸含量的剖宫产;2)“新生儿预后欠佳”,包括5分钟Apgar评分< 7、脐带动脉pH < 7.15、转至新生儿病房或围产期死亡。评估胎儿多普勒异常与预后标准之间的关系。结果:在所招募的116名妇女(占所有分娩的12.3%)中,30名(25.9%)在分娩期间进行了医疗干预,16名(13.8%)的新生儿结局不理想。产前FHR或羊水过少与任何主要结局均无关联。UA-RI和脑胎盘比与分娩期间医疗干预的需要密切相关(OR [95% CI]分别为13.1[1.4 - 122.2]和5.1[1.3 - 19.7]),但与新生儿结局的发生或次优结局无关。如果对临床工作人员可用,异常的胎儿多普勒将导致12次额外的引产,并在分娩过程中充分识别13种干预措施,包括6次因异常FHR而进行的剖腹产。结论:41周以上胎儿多普勒异常可能有助于更好地识别分娩过程中胎儿关注的危险情况。需要进一步的研究来评估其在长期妊娠管理中的应用前景。
{"title":"Fetal monitoring in pregnancies at and beyond 41 completed weeks: Prospective blind observational study of the use of umbilical and middle cerebral artery Doppler","authors":"Jeremy Boujenah,&nbsp;Bernard Benoit,&nbsp;Reda Djafer,&nbsp;Jacques Raiga,&nbsp;Guillaume Benoist,&nbsp;Bruno Carbonne","doi":"10.1016/j.jogoh.2025.103054","DOIUrl":"10.1016/j.jogoh.2025.103054","url":null,"abstract":"<div><h3>Objectives</h3><div>To assess the association of umbilical and middle cerebral artery Doppler, with the need for medical intervention during labor and the occurrence of adverse neonatal outcome in pregnancies at/or beyond 41 weeks.</div></div><div><h3>Methods</h3><div>Prospective, observational study of all pregnant women at 41 weeks and beyond during one year in a single Maternity Unit. Doppler measurements of umbilical artery and middle cerebral artery resistance indices (UA-RI and MCA-RI) and cerebro placental ratio (CPR) were performed at 41 weeks, blinded to the clinical staff. Clinical management of prolonged pregnancy was based on routine antepartum fetal heart rate (FHR) monitoring and ultrasound assessment of oligohydramnios. The main outcome measures were 2 composite criteria: 1) “medical intervention during labor” including any of cesarean delivery for FHR abnormalities and/or need for fetal scalp blood sampling for lactate measurement; and 2) “suboptimal neonatal outcome” including any of 5-min Apgar score &lt; 7, umbilical cord artery pH &lt; 7.15, transfer to neonatal unit or perinatal death. The association between abnormal fetal Doppler and the outcome criteria was assessed.</div></div><div><h3>Results</h3><div>Out of 116 women recruited (12.3 % of all deliveries), 30 (25.9 %) had a medical intervention during labor and 16 (13.8 %) had a suboptimal neonatal outcome. None of antepartum FHR or oligohydramnios were associated with any of the primary outcomes. UA-RI and cerebro-placental ratio were strongly associated with the need for a medical intervention during labor (OR [95 % CI] 13.1 [1.4 – 122.2] and 5.1 [1.3 19.7], respectively) but not with the occurrence or a suboptimal neonatal outcome. If made available to the clinical staff, abnormal fetal Dopplers could have led to 12 additional inductions of labor and to the adequate identification of 13 interventions during labor including 6 cesareans for abnormal FHR.</div></div><div><h3>Conclusion</h3><div>Abnormal fetal Doppler beyond 41 weeks may help to better identify situations at risk for medical intervention for fetal concern during labor. Further studies are necessary to assess its prospective use for the management of prolonged pregnancies</div></div>","PeriodicalId":15871,"journal":{"name":"Journal of gynecology obstetrics and human reproduction","volume":"55 1","pages":"Article 103054"},"PeriodicalIF":1.6,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145312969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary on "Impact of a national public health plan on the time frame for moderate and severe endometriosis diagnosis" 致编辑的信-关于“国家公共卫生计划对中度和重度子宫内膜异位症诊断时间框架的影响”的评论。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-10-06 DOI: 10.1016/j.jogoh.2025.103048
Ruihang Luo , Maosen Liu , Wei Zhong , Jian Bo Wu , Yuxin Fan , Mingshan Liu
{"title":"Commentary on \"Impact of a national public health plan on the time frame for moderate and severe endometriosis diagnosis\"","authors":"Ruihang Luo ,&nbsp;Maosen Liu ,&nbsp;Wei Zhong ,&nbsp;Jian Bo Wu ,&nbsp;Yuxin Fan ,&nbsp;Mingshan Liu","doi":"10.1016/j.jogoh.2025.103048","DOIUrl":"10.1016/j.jogoh.2025.103048","url":null,"abstract":"","PeriodicalId":15871,"journal":{"name":"Journal of gynecology obstetrics and human reproduction","volume":"54 10","pages":"Article 103048"},"PeriodicalIF":1.6,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145251115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors associated with mode of delivery in large-for-gestational-age fetuses: A retrospective cohort study 与大胎龄胎儿分娩方式相关的因素:一项回顾性队列研究。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-10-04 DOI: 10.1016/j.jogoh.2025.103047
Salomé Azeroual, Mohamed Dakin, Théo Joannes, Olivier Graesslin, René Gabriel, Benjamin Birene

Background

Large-for-gestational-age (LGA) fetuses are often associated with increased maternal and neonatal morbidity. Although suspicion of LGA can prompt closer surveillance and interventions such as labor induction, the actual impact on delivery outcomes and complications remains controversial.

Purpose

To assess maternal and fetal factors associated with the mode of delivery in pregnancies with LGA fetuses.

Basic procedures

Retrospective, single-center study (2018–2021) including term, singleton pregnancies with birthweight ≥ 90th percentile (AUDIPOG). Exclusion criteria were prior cesarean, multiples, preterm birth, non-cephalic presentation, planned cesarean, maternal request, or incomplete records. Primary outcome was mode of delivery. Multiple logistic regression was used.

Main findings

A total of 211 women met inclusion criteria. The rate of operative delivery (cesarean or instrumental vaginal birth) was 32.2% (68/211). In multiple logistic regression, nulliparity (OR 8.1, 95% CI 3.2–20.5, p < 0.001), induction of labor (OR 2.6, 95% CI 1.1–6.3, p = 0.035), greater gestational weight gain (OR 1.07 per kg, 95% CI 1.01–1.14, p = 0.021), and prenatal suspicion of macrosomia (EFW > 90th percentile at growth or third-trimester ultrasound, OR 2.9, 95% CI 1.2–7.1, p = 0.019) were independently associated with an increased risk of non-spontaneous birth. Maternal age, diabetes, and a history of LGA were not significantly associated after adjustment. Neonatal outcomes were favorable, with only one case of umbilical arterial pH < 7.00 (0.5%) and no severe traumatic complications.

Conclusions

In LGA pregnancies, nulliparity and suspected macrosomia were associated with higher rates of medical intervention, whereas induction and prior vaginal delivery favored spontaneous birth. Neonatal weight did not differ between delivery modes. These findings underscore the complexity of managing suspected LGA fetuses and the need for prospective multicenter studies to refine risk stratification.
背景:大胎龄(LGA)胎儿通常与母体和新生儿发病率增加有关。虽然对LGA的怀疑可以促使更密切的监测和干预措施,如引产,但对分娩结果和并发症的实际影响仍存在争议。目的:评估与LGA胎儿妊娠分娩方式相关的母胎因素。基本程序:回顾性、单中心研究(2018-2021),包括足月、单胎妊娠,出生体重≥90百分位(AUDIPOG)。排除标准为既往剖宫产、多胎、早产、非头位表现、计划剖宫产、产妇要求或记录不完整。主要结局是分娩方式。采用多元逻辑回归。主要发现:共有211名女性符合纳入标准。手术分娩(剖宫产或顺产)率为32.2%(68/211)。在多元logistic回归中,无产(OR 8.1, 95% CI 3.2-20.5, p < 0.001)、引产(OR 2.6, 95% CI 1.1-6.3, p = 0.035)、妊娠体重增加(OR 1.07 / kg, 95% CI 1.01-1.14, p = 0.021)和产前怀疑巨大儿(EFW bb0生长或妊娠晚期超声第90百分位,OR 2.9, 95% CI 1.2-7.1, p = 0.019)与非自然分娩风险增加独立相关。调整后,产妇年龄、糖尿病和LGA病史无显著相关。新生儿结局良好,仅有1例脐动脉pH < 7.00(0.5%),无严重创伤性并发症。结论:在LGA妊娠中,无产和疑似巨大儿与较高的医疗干预率相关,而诱导和阴道分娩倾向于自然分娩。新生儿体重在分娩方式之间没有差异。这些发现强调了处理疑似LGA胎儿的复杂性,以及前瞻性多中心研究以完善风险分层的必要性。
{"title":"Factors associated with mode of delivery in large-for-gestational-age fetuses: A retrospective cohort study","authors":"Salomé Azeroual,&nbsp;Mohamed Dakin,&nbsp;Théo Joannes,&nbsp;Olivier Graesslin,&nbsp;René Gabriel,&nbsp;Benjamin Birene","doi":"10.1016/j.jogoh.2025.103047","DOIUrl":"10.1016/j.jogoh.2025.103047","url":null,"abstract":"<div><h3>Background</h3><div>Large-for-gestational-age (LGA) fetuses are often associated with increased maternal and neonatal morbidity. Although suspicion of LGA can prompt closer surveillance and interventions such as labor induction, the actual impact on delivery outcomes and complications remains controversial.</div></div><div><h3>Purpose</h3><div>To assess maternal and fetal factors associated with the mode of delivery in pregnancies with LGA fetuses.</div></div><div><h3>Basic procedures</h3><div>Retrospective, single-center study (2018–2021) including term, singleton pregnancies with birthweight ≥ 90th percentile (AUDIPOG). Exclusion criteria were prior cesarean, multiples, preterm birth, non-cephalic presentation, planned cesarean, maternal request, or incomplete records. Primary outcome was mode of delivery. Multiple logistic regression was used.</div></div><div><h3>Main findings</h3><div>A total of 211 women met inclusion criteria. The rate of operative delivery (cesarean or instrumental vaginal birth) was 32.2% (68/211). In multiple logistic regression, nulliparity (OR 8.1, 95% CI 3.2–20.5, <em>p</em> &lt; 0.001), induction of labor (OR 2.6, 95% CI 1.1–6.3, <em>p</em> = 0.035), greater gestational weight gain (OR 1.07 per kg, 95% CI 1.01–1.14, <em>p</em> = 0.021), and prenatal suspicion of macrosomia (EFW &gt; 90th percentile at growth or third-trimester ultrasound, OR 2.9, 95% CI 1.2–7.1, <em>p</em> = 0.019) were independently associated with an increased risk of non-spontaneous birth. Maternal age, diabetes, and a history of LGA were not significantly associated after adjustment. Neonatal outcomes were favorable, with only one case of umbilical arterial pH &lt; 7.00 (0.5%) and no severe traumatic complications.</div></div><div><h3>Conclusions</h3><div>In LGA pregnancies, nulliparity and suspected macrosomia were associated with higher rates of medical intervention, whereas induction and prior vaginal delivery favored spontaneous birth. Neonatal weight did not differ between delivery modes. These findings underscore the complexity of managing suspected LGA fetuses and the need for prospective multicenter studies to refine risk stratification.</div></div>","PeriodicalId":15871,"journal":{"name":"Journal of gynecology obstetrics and human reproduction","volume":"54 10","pages":"Article 103047"},"PeriodicalIF":1.6,"publicationDate":"2025-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145238828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of GLP-1 receptor agonists in obstetrics and perinatal outcomes: A systematic review and meta-analysis 评估GLP-1受体激动剂在产科和围产期结局:系统回顾和荟萃分析。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-10-04 DOI: 10.1016/j.jogoh.2025.103046
Bruna Benigna Sales Armstrong , Ana Clara Pimenta Servidoni , Giovanna Cristina de Castro Martin , Guilherme Franceschini Machado , Wellgner Fernandes Oliveira Amador , Abdelrahman Yousif

Objective

Primary endpoint is maternal and fetal complications during pregnancy, labor, and delivery after exposure to GLP-1 receptor agonists.

Data Sources

A systematic search was conducted across PubMed, Embase, and Cochrane Central databases, including studies published from 2020 to 2025.

Study eligibility criteria

Included studies: (1) RCTs or cohorts; (2) exposure to GLP-1 RAs during pregnancy or preconception; (3) control group not exposed to GLP-1 RAs. Excluded studies: (1) without outcomes of interest; (2) lacking data transparency; (3) retracted; (4) abstracts, case reports, reviews; (5) no control group.

Study appraisal and synthesis methods

Six studies evaluated GLP-1 RA exposure during preconception or first trimester. Two authors screened studies; a third resolved disagreements. Risk of bias was assessed with ROBINS-I and RoB 2. Meta-analysis pooled continuous outcomes with mean differences and binary outcomes with odds ratios. Heterogeneity was evaluated via Cochrane Q and I². Subgroup analysis focused on first-trimester exposure.

Results

No statistically significant differences in pregnancy outcomes between GLP-1 RA and control group, including fetal growth restriction or small for gestational age (p = 0.12), live births (p = 0.10), major birth defects (p = 0.79), miscarriages (p = 0.41), preterm delivery (p = 0.62); and stillbirths (p = 0.09). GLP-1 RAs were linked to a lower risk of congenital heart defects (p = 0.03), even in the subgroup analysis (p = 0.03), and showed no significant protective effect against gestational diabetes (p = 0.49). In subgroup analysis, there were no notable differences in miscarriage (p = 0.32), major birth defects (p = 0.83) and preterm delivery (p = 0.88); there were fewer live births that did not reach statistical significance (p = 0.06).

Conclusion

No statistically significant difference was observed between the control and intervention groups. GLP-1 RAs were connected to a lower risk of congenital heart defects.
目的:主要终点是暴露于GLP-1受体激动剂后妊娠、分娩和分娩期间的母体和胎儿并发症。数据来源:对PubMed、Embase和Cochrane Central数据库进行系统检索,包括2020年至2025年发表的研究。研究资格标准:纳入研究:(1)随机对照试验或队列;(2)妊娠期或孕前暴露于GLP-1 RAs;(3)未暴露GLP-1 RAs的对照组。排除的研究:(1)没有感兴趣的结果;(2)缺乏数据透明度;(3)收回;(四)摘要、病例报告、综述;(5)无对照组。研究评价和合成方法:六项研究评估了孕前或妊娠早期GLP-1 RA暴露。两位作者筛选了研究;第三个解决了分歧。采用robins - 1和rob2评估偏倚风险。荟萃分析汇集了具有平均差异的连续结果和具有优势比的二元结果。通过Cochrane Q和I²评估异质性。亚组分析侧重于妊娠早期暴露。结果:在妊娠结果没有明显的统计学差异GLP-1 RA和对照组之间,包括胎龄的胎儿生长受限或小(p = 0.12),活产(p = 0.10),主要出生缺陷(p = 0.79),流产(p = 0.41),早产(p = 0.62);和死产(p = 0.09)。即使在亚组分析中(p = 0.03),GLP-1 RAs也与较低的先天性心脏缺陷风险相关(p = 0.03),并且对妊娠糖尿病没有显着的保护作用(p = 0.49)。亚组分析中,流产(p = 0.32)、重大出生缺陷(p = 0.83)、早产(p = 0.88)两组间差异无统计学意义;活产数较少,差异无统计学意义(p = 0.06)。结论:对照组与干预组之间无统计学差异。GLP-1 RAs与先天性心脏缺陷的风险较低有关。
{"title":"Evaluation of GLP-1 receptor agonists in obstetrics and perinatal outcomes: A systematic review and meta-analysis","authors":"Bruna Benigna Sales Armstrong ,&nbsp;Ana Clara Pimenta Servidoni ,&nbsp;Giovanna Cristina de Castro Martin ,&nbsp;Guilherme Franceschini Machado ,&nbsp;Wellgner Fernandes Oliveira Amador ,&nbsp;Abdelrahman Yousif","doi":"10.1016/j.jogoh.2025.103046","DOIUrl":"10.1016/j.jogoh.2025.103046","url":null,"abstract":"<div><h3>Objective</h3><div>Primary endpoint is maternal and fetal complications during pregnancy, labor, and delivery after exposure to GLP-1 receptor agonists.</div></div><div><h3>Data Sources</h3><div>A systematic search was conducted across PubMed, Embase, and Cochrane Central databases, including studies published from 2020 to 2025.</div></div><div><h3>Study eligibility criteria</h3><div>Included studies: (1) RCTs or cohorts; (2) exposure to GLP-1 RAs during pregnancy or preconception; (3) control group not exposed to GLP-1 RAs. Excluded studies: (1) without outcomes of interest; (2) lacking data transparency; (3) retracted; (4) abstracts, case reports, reviews; (5) no control group.</div></div><div><h3>Study appraisal and synthesis methods</h3><div>Six studies evaluated GLP-1 RA exposure during preconception or first trimester. Two authors screened studies; a third resolved disagreements. Risk of bias was assessed with ROBINS-I and RoB 2. Meta-analysis pooled continuous outcomes with mean differences and binary outcomes with odds ratios. Heterogeneity was evaluated via Cochrane Q and I². Subgroup analysis focused on first-trimester exposure.</div></div><div><h3>Results</h3><div>No statistically significant differences in pregnancy outcomes between GLP-1 RA and control group, including fetal growth restriction or small for gestational age (<em>p</em> = 0.12), live births (<em>p</em> = 0.10), major birth defects (<em>p</em> = 0.79), miscarriages (<em>p</em> = 0.41), preterm delivery (<em>p</em> = 0.62); and stillbirths (<em>p</em> = 0.09). GLP-1 RAs were linked to a lower risk of congenital heart defects (<em>p</em> = 0.03), even in the subgroup analysis (<em>p</em> = 0.03), and showed no significant protective effect against gestational diabetes (<em>p</em> = 0.49). In subgroup analysis, there were no notable differences in miscarriage (<em>p</em> = 0.32), major birth defects (<em>p</em> = 0.83) and preterm delivery (<em>p</em> = 0.88); there were fewer live births that did not reach statistical significance (<em>p</em> = 0.06).</div></div><div><h3>Conclusion</h3><div>No statistically significant difference was observed between the control and intervention groups. GLP-1 RAs were connected to a lower risk of congenital heart defects.</div></div>","PeriodicalId":15871,"journal":{"name":"Journal of gynecology obstetrics and human reproduction","volume":"54 10","pages":"Article 103046"},"PeriodicalIF":1.6,"publicationDate":"2025-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145238846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Favorable pregnancy outcome in a woman with extensive disseminated peritoneal leiomyomatosis 广泛播散性腹膜平滑肌瘤病患者妊娠结局良好。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-10-03 DOI: 10.1016/j.jogoh.2025.103045
E. Hagelauer , M. Beck , C. Rousset-Jablonski , E. Ruaux , A. Trecourt , P. Rousset , W. Gertych
Disseminated peritoneal leiomyomatosis (DPL) is a rare and benign condition characterized by the progression of smooth muscle tumors across the peritoneal cavity. The etiology is not well understood and could include previous surgeries and hormonal stimulation. We report on a 39-year-old woman with extensive DPL at the end of her pregnancy. She was diagnosed in the context of amenorrhea and was initially treated by gonadotropin-releasing hormone (GnRH) agonist. During pregnancy, a significant increase in lesion size was observed. The day before the planned cesarean-section (C-section), she presented with severe hypercalcemia, which was probably from a paraneoplastic origin. The patient underwent a planned C-section at 36 weeks and 5 days of gestation by midline sub-umbilical laparotomy, allowing a safe delivery.
This case provides insights for healthcare providers facing similar cases, considering that the obstetrical management of patients with DPL has not yet been defined.
播散性腹膜平滑肌瘤病(DPL)是一种罕见的良性疾病,其特征是平滑肌肿瘤在腹膜腔内的进展。病因尚不清楚,可能包括以前的手术和激素刺激。我们报告了一位39岁的女性,在她怀孕结束时患有广泛的DPL。她被诊断为闭经,最初使用促性腺激素释放激素(GnRH)激动剂治疗。在怀孕期间,观察到病变大小明显增加。在计划剖腹产的前一天,她出现了严重的高钙血症,可能是由副肿瘤引起的。患者在妊娠36周零5天通过脐下中线剖腹手术计划剖腹产,允许安全分娩。考虑到DPL患者的产科管理尚未明确,本病例为面临类似病例的医疗保健提供者提供了见解。
{"title":"Favorable pregnancy outcome in a woman with extensive disseminated peritoneal leiomyomatosis","authors":"E. Hagelauer ,&nbsp;M. Beck ,&nbsp;C. Rousset-Jablonski ,&nbsp;E. Ruaux ,&nbsp;A. Trecourt ,&nbsp;P. Rousset ,&nbsp;W. Gertych","doi":"10.1016/j.jogoh.2025.103045","DOIUrl":"10.1016/j.jogoh.2025.103045","url":null,"abstract":"<div><div>Disseminated peritoneal leiomyomatosis (DPL) is a rare and benign condition characterized by the progression of smooth muscle tumors across the peritoneal cavity. The etiology is not well understood and could include previous surgeries and hormonal stimulation. We report on a 39-year-old woman with extensive DPL at the end of her pregnancy. She was diagnosed in the context of amenorrhea and was initially treated by gonadotropin-releasing hormone (GnRH) agonist. During pregnancy, a significant increase in lesion size was observed. The day before the planned cesarean-section (C-section), she presented with severe hypercalcemia, which was probably from a paraneoplastic origin. The patient underwent a planned C-section at 36 weeks and 5 days of gestation by midline sub-umbilical laparotomy, allowing a safe delivery.</div><div>This case provides insights for healthcare providers facing similar cases, considering that the obstetrical management of patients with DPL has not yet been defined.</div></div>","PeriodicalId":15871,"journal":{"name":"Journal of gynecology obstetrics and human reproduction","volume":"54 10","pages":"Article 103045"},"PeriodicalIF":1.6,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145232810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound Follow-Up in young women with severe dysmenorrhea predicts early onset of endometriosis. 严重痛经的年轻女性超声随访预测早发性子宫内膜异位症。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-10-01 Epub Date: 2025-08-05 DOI: 10.1016/j.jogoh.2025.103003
Elvira Nocita, Francesco Giuseppe Martire, Chiara Paladino, Giulia Monaco, Federica Iacobini, Sara Valeriani, Giorgia Soreca, Consuelo Russo, Caterina Exacoustos

Objectives: To evaluate the progression of endometriosis and painful symptoms in young women (≤ 25 years) with severe dysmenorrhea (Visual Analogue Scale score ≥ 7), with or without ultrasound-detected endometriosis, over a follow-up period of 12 to 36 months. The impact of hormone therapy was also assessed.

Methods: This retrospective observational study included 124 young women with severe dysmenorrhea: 67 had ultrasound signs of endometriosis/adenomyosis, 57 did not. All patients with ultrasound-detected endometriosis/adenomyosis received continuous hormone therapy, inducing amenorrhea; those without ultrasound findings underwent either cyclic hormone therapy or no treatment. Clinical and ultrasound assessments were performed at baseline and at follow-up visits at 12, 24 and 36 months, recording all symptoms and disease sites.

Results: In patients with ultrasound-detected endometriosis on continuous hormone therapy, all painful symptoms improved, and endometrioma size significantly decreased, with 40 % resolving completely. Utero-sacral ligament lesions also shrank, while rectal endometriosis remained unchanged. Ultrasound direct signs of adenomyosis were no longer visible in 22 % of cases. In patients without initial ultrasound evidence of endometriosis and with a regular menstrual cycle, new ultrasound-detected endometriosis emerged in 20 % of cases at follow-up.

Conclusions: In young patients with severe dysmenorrhea, clinical and ultrasound follow-up supports early detection of endometriosis and an appropriate treatment may reduce symptoms and prevent disease progression.

目的:评估伴有或不伴有超声检测子宫内膜异位症的严重痛经(视觉模拟量表评分≥7)的年轻女性(≤25岁)的子宫内膜异位症和疼痛症状的进展,随访12至36个月。对激素治疗的影响也进行了评估。方法:本回顾性观察研究纳入124例严重痛经的年轻女性:67例有子宫内膜异位症/ bbb超声征象,57例无。所有超声诊断为子宫内膜异位症/子宫腺肌症的患者均接受持续激素治疗,诱发闭经;那些没有超声检查结果的人要么接受循环激素治疗,要么不接受治疗。在基线和随访12、24和36个月时进行临床和超声评估,记录所有症状和疾病部位。结果:超声检查的子宫内膜异位症患者持续激素治疗后,疼痛症状均得到改善,子宫内膜异位症大小明显减小,其中40%完全消退。子宫骶韧带病变也缩小,而直肠子宫内膜异位症保持不变。在22%的病例中,超声直接征象不再可见。在没有子宫内膜异位症初始超声证据且月经周期正常的患者中,20%的病例在随访中出现新的超声检测子宫内膜异位症。结论:对患有严重痛经的年轻患者,临床和超声随访有助于早期发现子宫内膜异位症,适当的治疗可以减轻症状并预防疾病进展。
{"title":"Ultrasound Follow-Up in young women with severe dysmenorrhea predicts early onset of endometriosis.","authors":"Elvira Nocita, Francesco Giuseppe Martire, Chiara Paladino, Giulia Monaco, Federica Iacobini, Sara Valeriani, Giorgia Soreca, Consuelo Russo, Caterina Exacoustos","doi":"10.1016/j.jogoh.2025.103003","DOIUrl":"10.1016/j.jogoh.2025.103003","url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the progression of endometriosis and painful symptoms in young women (≤ 25 years) with severe dysmenorrhea (Visual Analogue Scale score ≥ 7), with or without ultrasound-detected endometriosis, over a follow-up period of 12 to 36 months. The impact of hormone therapy was also assessed.</p><p><strong>Methods: </strong>This retrospective observational study included 124 young women with severe dysmenorrhea: 67 had ultrasound signs of endometriosis/adenomyosis, 57 did not. All patients with ultrasound-detected endometriosis/adenomyosis received continuous hormone therapy, inducing amenorrhea; those without ultrasound findings underwent either cyclic hormone therapy or no treatment. Clinical and ultrasound assessments were performed at baseline and at follow-up visits at 12, 24 and 36 months, recording all symptoms and disease sites.</p><p><strong>Results: </strong>In patients with ultrasound-detected endometriosis on continuous hormone therapy, all painful symptoms improved, and endometrioma size significantly decreased, with 40 % resolving completely. Utero-sacral ligament lesions also shrank, while rectal endometriosis remained unchanged. Ultrasound direct signs of adenomyosis were no longer visible in 22 % of cases. In patients without initial ultrasound evidence of endometriosis and with a regular menstrual cycle, new ultrasound-detected endometriosis emerged in 20 % of cases at follow-up.</p><p><strong>Conclusions: </strong>In young patients with severe dysmenorrhea, clinical and ultrasound follow-up supports early detection of endometriosis and an appropriate treatment may reduce symptoms and prevent disease progression.</p>","PeriodicalId":15871,"journal":{"name":"Journal of gynecology obstetrics and human reproduction","volume":" ","pages":"103003"},"PeriodicalIF":1.6,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144789308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What changes in the fetal heart rate are associated with neonatal acidosis during the second stage of labor? 产程第二阶段胎儿心率的哪些变化与新生儿酸中毒有关?
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-30 DOI: 10.1016/j.jogoh.2025.103043
G. Dhenin , S. Godin , N. Ramdane , H. Behal , C. Garabedian

Objective

To describe fetal heart rate (FHR) patterns associated with neonatal acidosis during the second stage of labor.

Method

This single-center (Lille, France) retrospective cohort study was conducted between September 2022 and January 2023. Fetal heart rate (FHR) during maternal expulsive efforts was interpreted for all low-risk women who delivered vaginally after 37 weeks' gestation. Low risk was defined by the absence of any maternal history, obstetric complications, and a normal fetal heart rate in the hour before the onset of expulsive efforts. A baseline increase was defined as a greater than 20 % increase in baseline FHR. Reduced variability and marked variability were defined as a variability <5 bpm and greater than 25 bpm, respectively. FHRs were also described according to Melchior's classification. Neonatal acidosis was defined as umbilical artery pH <7.15.

Results

Among the 275 expulsion FHRs analysed, 7.3 % (20/275) showed increased baseline and 5.5 % (15/275) abnormal variability. Neonatal acidosis occurred in 19.6 % (54/275) of neonates. Increased baseline and bradycardia were significantly associated with neonatal acidosis (14.8 % vs 5.4 %, p = 0.035 and 20.4 % vs 10.0 %, p = 0.035, respectively).

Conclusion

Increased baseline fetal heart rate during the second stage of labor was associated with a significant risk of neonatal acidosis. It would be interesting to include it in classifications related to this stage.
目的:探讨产程第二阶段与新生儿酸中毒相关的胎儿心率(FHR)模式。方法:该单中心(法国里尔)回顾性队列研究于2022年9月至2023年1月进行。对所有妊娠37周后顺产的低风险妇女进行排尿时的胎儿心率(FHR)分析。低风险定义为没有任何产妇史,产科并发症,在开始排尿前一小时胎儿心率正常。基线增加被定义为基线FHR增加超过20%。减少可变性和显著可变性分别被定义为小于5 bpm和大于25 bpm的可变性。fhr也根据Melchior的分类进行了描述。结果:在分析的275例驱逐fhr中,7.3%(20/275)显示基线升高,5.5%(15/275)显示异常变异性。新生儿酸中毒发生率为19.6%(54/275)。基线增高和心动过缓与新生儿酸中毒显著相关(分别为14.8%对5.4%,p=0.035和20.4%对10.0%,p=0.035)。结论:产程第二阶段胎儿基线心率升高与新生儿酸中毒风险显著相关。将其纳入与此阶段相关的分类将是有趣的。
{"title":"What changes in the fetal heart rate are associated with neonatal acidosis during the second stage of labor?","authors":"G. Dhenin ,&nbsp;S. Godin ,&nbsp;N. Ramdane ,&nbsp;H. Behal ,&nbsp;C. Garabedian","doi":"10.1016/j.jogoh.2025.103043","DOIUrl":"10.1016/j.jogoh.2025.103043","url":null,"abstract":"<div><h3>Objective</h3><div>To describe fetal heart rate (FHR) patterns associated with neonatal acidosis during the second stage of labor.</div></div><div><h3>Method</h3><div>This single-center (Lille, France) retrospective cohort study was conducted between September 2022 and January 2023. Fetal heart rate (FHR) during maternal expulsive efforts was interpreted for all low-risk women who delivered vaginally after 37 weeks' gestation. Low risk was defined by the absence of any maternal history, obstetric complications, and a normal fetal heart rate in the hour before the onset of expulsive efforts. A baseline increase was defined as a greater than 20 % increase in baseline FHR. Reduced variability and marked variability were defined as a variability &lt;5 bpm and greater than 25 bpm, respectively. FHRs were also described according to Melchior's classification. Neonatal acidosis was defined as umbilical artery pH &lt;7.15.</div></div><div><h3>Results</h3><div>Among the 275 expulsion FHRs analysed, 7.3 % (20/275) showed increased baseline and 5.5 % (15/275) abnormal variability. Neonatal acidosis occurred in 19.6 % (54/275) of neonates. Increased baseline and bradycardia were significantly associated with neonatal acidosis (14.8 % vs 5.4 %, <em>p</em> = 0.035 and 20.4 % vs 10.0 %, <em>p</em> = 0.035, respectively).</div></div><div><h3>Conclusion</h3><div>Increased baseline fetal heart rate during the second stage of labor was associated with a significant risk of neonatal acidosis. It would be interesting to include it in classifications related to this stage.</div></div>","PeriodicalId":15871,"journal":{"name":"Journal of gynecology obstetrics and human reproduction","volume":"54 10","pages":"Article 103043"},"PeriodicalIF":1.6,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145212862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of hyperhomocysteinemia with IVF live birth rate: A retrospective cohort study 高同型半胱氨酸血症与IVF活产率的关联:一项回顾性队列研究。
IF 1.6 4区 医学 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-30 DOI: 10.1016/j.jogoh.2025.103044
Lijun Shui , Xiaozhu Chen , Xianchao Dou , Liangyi Ni , Chao Chen , Xinyi Zhu , Qi Jin , Shun Bai , Limin Wu , Meihong Hu

Objective

Homocysteine (Hcy) has been reported to be associated with female reproduction. However, the correlation between hyperhomocysteinemia (HHcy) and pregnancy outcomes among infertile women remains unclear. This observational study aims to evaluate the effect of HHcy on pregnancy outcomes in infertile patients undergoing ART treatment.

Methods

Data were collected from 385 patients (50 in the HHcy group and 335 in the non-HHcy group) who underwent In Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) at the First Affiliated Hospital of University of Science and Technology of China. Clinical outcomes between the two groups were analyzed.

Results

The number of oocytes retrieved, MII oocytes, oocyte maturation rate and normal fertilization rate did not differ significantly between the two groups. However, the HHcy group exhibited significantly lower rates of biochemical pregnancy (48 % vs. 74.9 %), clinical pregnancy (38 % vs. 63.9 %) and live births (34 % vs. 52.8 %) in the HHcy group compared to non-HHcy group. Logistic regression analyses indicated that HHcy was negatively associated with biochemical pregnancy rate (OR= 0.28, 95 % CI: 0.14–0.54, P < 0.001), clinical pregnancy rate (OR = 0.32, 95 % CI: 0.16–0.61, P < 0.001) and live birth rate (OR = 0.45, 95 % CI: 0.23–0.86, P = 0.02).

Conclusion

HHcy exhibited a negative correlation with live birth among patients underwent IVF/ICSI. Clinicians should consider focusing more attention on patients with HHcy to enhance ART outcomes.
目的:同型半胱氨酸(Hcy)已被报道与女性生殖有关。然而,高同型半胱氨酸血症(HHcy)与不孕妇女妊娠结局之间的相关性尚不清楚。本观察性研究旨在评估HHcy对接受ART治疗的不孕症患者妊娠结局的影响。方法:收集在中国科学技术大学第一附属医院接受体外受精/胞浆内单精子注射(IVF/ICSI)治疗的385例患者(HHcy组50例,非HHcy组335例)的资料。分析两组患者的临床结果。结果:两组获卵数、MII卵母细胞数、卵母细胞成熟率及正常受精率均无显著差异。然而,与非HHcy组相比,HHcy组的生化妊娠率(48% vs. 74.9%)、临床妊娠率(38% vs. 63.9%)和活产率(34% vs. 52.8%)明显低于HHcy组。Logistic回归分析显示,HHcy与生化妊娠率(OR= 0.28, 95% CI: 0.14-0.54, P < 0.001)、临床妊娠率(OR = 0.32,95% CI: 0.16-0.61, P < 0.001)、活产率(OR = 0.45,95% CI: 0.23-0.86, P = 0.02)呈负相关。结论:HHcy与IVF/ICSI患者的活产率呈负相关。临床医生应考虑将更多的注意力放在HHcy患者身上,以提高抗逆转录病毒治疗的效果。
{"title":"Association of hyperhomocysteinemia with IVF live birth rate: A retrospective cohort study","authors":"Lijun Shui ,&nbsp;Xiaozhu Chen ,&nbsp;Xianchao Dou ,&nbsp;Liangyi Ni ,&nbsp;Chao Chen ,&nbsp;Xinyi Zhu ,&nbsp;Qi Jin ,&nbsp;Shun Bai ,&nbsp;Limin Wu ,&nbsp;Meihong Hu","doi":"10.1016/j.jogoh.2025.103044","DOIUrl":"10.1016/j.jogoh.2025.103044","url":null,"abstract":"<div><h3>Objective</h3><div>Homocysteine (Hcy) has been reported to be associated with female reproduction. However, the correlation between hyperhomocysteinemia (HHcy) and pregnancy outcomes among infertile women remains unclear. This observational study aims to evaluate the effect of HHcy on pregnancy outcomes in infertile patients undergoing ART treatment.</div></div><div><h3>Methods</h3><div>Data were collected from 385 patients (50 in the HHcy group and 335 in the non-HHcy group) who underwent In Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) at the First Affiliated Hospital of University of Science and Technology of China. Clinical outcomes between the two groups were analyzed.</div></div><div><h3>Results</h3><div>The number of oocytes retrieved, MII oocytes, oocyte maturation rate and normal fertilization rate did not differ significantly between the two groups. However, the HHcy group exhibited significantly lower rates of biochemical pregnancy (48 % vs. 74.9 %), clinical pregnancy (38 % vs. 63.9 %) and live births (34 % vs. 52.8 %) in the HHcy group compared to non-HHcy group. Logistic regression analyses indicated that HHcy was negatively associated with biochemical pregnancy rate (OR= 0.28, 95 % CI: 0.14–0.54, <em>P</em> &lt; 0.001), clinical pregnancy rate (OR = 0.32, 95 % CI: 0.16–0.61, <em>P</em> &lt; 0.001) and live birth rate (OR = 0.45, 95 % CI: 0.23–0.86, <em>P</em> = 0.02).</div></div><div><h3>Conclusion</h3><div>HHcy exhibited a negative correlation with live birth among patients underwent IVF/ICSI. Clinicians should consider focusing more attention on patients with HHcy to enhance ART outcomes.</div></div>","PeriodicalId":15871,"journal":{"name":"Journal of gynecology obstetrics and human reproduction","volume":"54 10","pages":"Article 103044"},"PeriodicalIF":1.6,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145212829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of gynecology obstetrics and human reproduction
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1